The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study

SIMPLE SUMMARY: The treatment of advanced pancreatic cancer represents a major challenge because of its chemoresistance and low survival rate. The aim of this research is to test a new antitumor agent (sodium selenite) in pancreatic cancer, both in vitro and in vivo, focusing on the molecular mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Doello, Kevin, Mesas, Cristina, Quiñonero, Francisco, Perazzoli, Gloria, Cabeza, Laura, Prados, Jose, Melguizo, Consolacion, Ortiz, Raul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268835/
https://www.ncbi.nlm.nih.gov/pubmed/34201986
http://dx.doi.org/10.3390/cancers13133169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268835/
https://www.ncbi.nlm.nih.gov/pubmed/34201986
http://dx.doi.org/10.3390/cancers13133169

Ejemplares similares